PepGen Ltd.. (3/27/18). "Press Release: PepGen Has Launched".

	Region	Oxford, Oxfordshire
	Country	United Kingdom (GB)
	Organisation	PepGen Ltd.
	Today	PepGen (Group)
	Group	PepGen (Group)
	Organisation 2	Oxford Sciences Innovation plc (OSI)
	Group	University of Oxford
	Product	EDO technology (enhanced delivery oligonucleotides) (PepGen)
	Product 2	venture capital
	Index term	PepGen–Univ Oxford: investment, 201803– seed investment £4.5m from Oxford Sciences Innovation
	Person	Godfrey, Caroline (PepGen 201912 CEO + Academic Founder)
	Person 2	Campion, Giles (Prosensa 201309 CMO)

On 26th March 2018 PepGen, a biotech company focused on the peptide-mediated delivery of nucleic acids, was spun out from the University of Oxford (OU) and the Medical Research Council (MRC). The intellectual property underpinning PepGen’s technology platform was developed through a decade-long collaboration between Professor Matthew Wood (OU) and Dr Michael Gait (MRC). The company’s co-founders are Dr Caroline Godfrey and Dr Giles Campion, with Dr Godfrey taking the role of CEO.

PepGen has received an initial £2.5M of seed funding from Oxford Sciences Innovation (OSI), and will focus on the pre-clinical validation of the company’s peptide delivery platform before building towards the commercialisation of this technology across a broad range of indications. These activities will be guided and supported by PepGen’s founding Board of Directors, Dr Wood, Dr Godfrey and Dr Andrew Mclean (OSI).

Record changed: 2021-02-07